Literature DB >> 10513752

Problems with using capture-recapture in epidemiology: an example of a measles epidemic.

R M Cormack1.   

Abstract

Capture-recapture is becoming widely used in epidemiology to estimate disease prevalence or sizes of population at risk. When such estimates are obtained from uncontrolled observation of existing lists, a huge act of faith is required, usually without any scientific justification. Fitting of loglinear models appears to offer some hope but contains major problems of analysis and interpretation. These are illustrated by reanalysis of data on a measles epidemic-see McGilchrist et al. 1996 [J Clin Epidemiol 49, pp. 293-296]--for which the wrong model was selected. It is argued that the measles lists contained so few overlaps that no reliable information is provided by that study about the size of the epidemic.

Mesh:

Year:  1999        PMID: 10513752     DOI: 10.1016/s0895-4356(99)00058-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

1.  Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.

Authors:  Stephanie Lugardon; Karine Desboeuf; Pierre Fernet; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

2.  Completeness of notification of tuberculosis in The Netherlands: how reliable is record-linkage and capture-recapture analysis?

Authors:  N A H van Hest; F Smit; H W M Baars; G De Vries; P E W De Haas; P J Westenend; N J D Nagelkerke; J H Richardus
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

3.  Underreporting of meningococcal disease incidence in the Netherlands: results from a capture-recapture analysis based on three registration sources with correction for false positive diagnoses.

Authors:  Sabine C de Greeff; Lodewijk Spanjaard; Jacob Dankert; Christian J P A Hoebe; Nico Nagelkerke; Hester E de Melker
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  Estimating infectious diseases incidence: validity of capture-recapture analysis and truncated models for incomplete count data.

Authors:  N A H van Hest; A D Grant; F Smit; A Story; J H Richardus
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

5.  Incidence and completeness of notification of Legionnaires' disease in The Netherlands: covariate capture-recapture analysis acknowledging regional differences.

Authors:  N A H Van Hest; C J P A Hoebe; J W Den Boer; J K Vermunt; E P F Ijzerman; W G Boersma; J H Richardus
Journal:  Epidemiol Infect       Date:  2007-06-22       Impact factor: 2.451

6.  A decline in the prevalence of injecting drug users in Estonia, 2005-2009.

Authors:  Anneli Uusküla; Kristiina Rajaleid; Ave Talu; Katri Abel-Ollo; Don C Des Jarlais
Journal:  Int J Drug Policy       Date:  2013-01-03

7.  Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study.

Authors:  H M Fortnum; A Q Summerfield; D H Marshall; A C Davis; J M Bamford
Journal:  BMJ       Date:  2001-09-08

8.  Record-linkage and capture-recapture analysis to estimate the incidence and completeness of reporting of tuberculosis in England 1999-2002.

Authors:  N A H VAN Hest; A Story; A D Grant; D Antoine; J P Crofts; J M Watson
Journal:  Epidemiol Infect       Date:  2008-03-17       Impact factor: 2.451

9.  Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998-2007.

Authors:  Joao de Sá; Enrique Alcalde-Cabero; Javier Almazán-Isla; Fernando García-López; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2014-12-21       Impact factor: 2.474

10.  Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.

Authors:  Hayley E Jones; Matthew Hickman; Nicky J Welton; Daniela De Angelis; Ross J Harris; A E Ades
Journal:  Am J Epidemiol       Date:  2014-04-11       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.